IgM antiphospholipid antibodies are associated with a microvascular phenotype in antiphospholipid syndrome

Abstract Background The clinical significance of IgM antiphospholipid antibodies (aPL) in antiphospholipid syndrome (APS) remains uncertain, while lupus anticoagulant is a well-established marker for thrombotic risk. Methods The objective of the study is to evaluate the impact of IgM aPL on the clin...

Full description

Bibliographic Details
Published in:Advances in Rheumatology
Main Authors: Flavio Signorelli, Fernanda Oliveira de Andrade Lopes, Andreia Coimbra Sousa Gomes, Gustavo Guimarães Moreira Balbi, Irene Cecchi, Massimo Radin, Savino Sciascia, Danieli Castro Oliveira de Andrade
Format: Article
Language:English
Published: BMC 2026-06-01
Subjects:
Antiphospholipid syndrome
Antiphospholipid antibodies
Lupus anticoagulant
Online Access:https://doi.org/10.1186/s42358-026-00553-z

Internet

https://doi.org/10.1186/s42358-026-00553-z

Similar Items